Zalcman G - Search Results

1

[What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?].

Moro-Sibilot D, Pluquet E, Zalcman G, Bréchot JM, Souquet PJ, Debieuvre D, Morin F, Morère JF. Moro-Sibilot D, et al. Among authors: zalcman g. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S120-4. Rev Mal Respir. 2007. PMID: 18235404 Review. French.

2

Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer.

Zalcman G, Trédaniel J, Schlichtholz B, Urban T, Milleron B, Lubin R, Meignin V, Couderc LJ, Hirsch A, Soussi T. Zalcman G, et al. Int J Cancer. 2000 Jan 20;89(1):81-6. doi: 10.1002/(sici)1097-0215(20000120)89:1<81::aid-ijc13>3.0.co;2-i. Int J Cancer. 2000. PMID: 10719735 Free article.

3

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer.

Quoix E, Lebeau B, Depierre A, Ducolone A, Moro-Sibilot D, Milleron B, Breton JL, Lemarie E, Pujol JL, Brechot JM, Zalcman G, Debieuvre D, Vaylet F, Vergnenegre A, Clouet P. Quoix E, et al. Among authors: zalcman g. Ann Oncol. 2004 Jan;15(1):38-44. doi: 10.1093/annonc/mdh005. Ann Oncol. 2004. PMID: 14679117 Free article. Clinical Trial.

4

[A special issue of the Revue des Maladies Respiratoires dedicated to the courses of the Groupe d'Oncologie de Langue Française, in 2005].

Zalcman G, Barlesi F, Bréchot JM. Zalcman G, et al. Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S5-7. Rev Mal Respir. 2005. PMID: 16340829 French. No abstract available.

5

[Adjuvant chemotherapy for stage IB non small cell lung cancer: the standard of care?].

Carré PC, Zalcman G. Carré PC, et al. Among authors: zalcman g. Rev Mal Respir. 2006 Sep;23(4 Pt 1):295-7. doi: 10.1016/s0761-8425(06)71593-5. Rev Mal Respir. 2006. PMID: 17127903 Review. French. No abstract available.

6

[The place of targeted therapies in the management of non-small cell bronchial carcinoma. Biological mechanisms of bronchial carcinogenesis: towards a better understanding and the development of new therapies].

Zalcman G, Richard N, Madelaine J, Bergot E. Zalcman G, et al. Rev Mal Respir. 2006 Nov;23(5 Pt 3):16S123-16S130. Rev Mal Respir. 2006. PMID: 17268349 Review. French.

7

[Primitive metastasizing bronchial carcinoid with long survival].

Bouvier N, Zengerling V, Halley A, Le Pennec V, Le Rochais JP, Madelaine J, Galateau-Salle F, Bergot E, Zalcman G. Bouvier N, et al. Among authors: zalcman g. Rev Mal Respir. 2007 Jan;24(1):63-8. Rev Mal Respir. 2007. PMID: 17268367 French.

8

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT). Westeel V, et al. Among authors: zalcman g. Rev Mal Respir. 2007 May;24(5):645-52. doi: 10.1016/s0761-8425(07)91135-3. Rev Mal Respir. 2007. PMID: 17519819 Clinical Trial. French.

9

[The GOLF thoracic oncology course... or how to learn everything or nearly everything in thoracic oncology].

Barlési F, Bréchot JM, Zalcman G. Barlési F, et al. Among authors: zalcman g. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S5-7. Rev Mal Respir. 2007. PMID: 18235387 French. No abstract available.

10

[Mechanisms of action of targeted therapies... and mechanisms of resistance].

Bergot E, Richard N, Zalcman G. Bergot E, et al. Among authors: zalcman g. Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S180-7. Rev Mal Respir. 2007. PMID: 18235412 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page